Every material Form 8-K Advasa Holdings, Inc. has filed with the SEC since October 22, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Advasa Holdings, Inc. disclosed that director Ferdinand Groenewald resigned from its Board of Directors, including all committee appointments, effective with notice on October 26, 2026. The company says the departure is for personal reasons and not due to any disagreement with management or the board about operations, policies or practices. The filing does not name a replacement or describe any change to financial results.
Ferdinand Groenewald resigned from the Board of Directors on October 26, 2026.
His resignation includes all committee appointments.
The company states the departure is for personal reasons, with no disagreements on operations, policies or practices.
The filing was signed October 30, 2026 by CEO Grady Ryther and names no successor.
Advasa Holdings received a Nasdaq notice on October 21, 2026, saying its common stock had closed below the $1.00 per share minimum bid price for 30 consecutive business days. The company has until April 19, 2027 to regain compliance, which requires meeting the standard for at least 10 consecutive business days, and the filing says it may transfer to the Nasdaq Capital Market or face delisting if it does not. The notice has no immediate effect, and the stock continues to trade as ADBT on the Nasdaq Global Market.
Nasdaq notice received October 21, 2026, under Listing Rule 5450(a)(1)
Stock must meet the $1.00 minimum bid price for 10 consecutive business days before April 19, 2027 to regain compliance
If not compliant by April 19, 2027, the company may transfer to the Nasdaq Capital Market or receive a delisting notice that it could appeal
Common stock continues trading as ADBT on the Nasdaq Global Market for now
Advasa Holdings said its largest stockholder, Asamitsu Kosugi, intends to surrender 97,413,140 common shares to the company for no consideration, about 20% of outstanding stock. The shares would be cancelled, reducing the share count by roughly 20%, but the transaction is not complete and depends on documentation, corporate approvals and transfer agent procedures.
Mr. Kosugi, the largest stockholder, intends to surrender 97,413,140 shares for no consideration.
The shares represent approximately 20% of total outstanding common stock as of the report date.
Completion is subject to documentation, corporate approvals and transfer agent procedures; no timing was given.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Advasa Holdings, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →